PCI Biotech Holding Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for PCI Biotech Holding.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth2.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

We're Keeping An Eye On PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

Aug 05
We're Keeping An Eye On PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

We Think PCI Biotech Holding (OB:PCIB) Needs To Drive Business Growth Carefully

Apr 21
We Think PCI Biotech Holding (OB:PCIB) Needs To Drive Business Growth Carefully

We're Hopeful That PCI Biotech Holding (OB:PCIB) Will Use Its Cash Wisely

Dec 16
We're Hopeful That PCI Biotech Holding (OB:PCIB) Will Use Its Cash Wisely

We're Not Very Worried About PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

Apr 09
We're Not Very Worried About PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

What Type Of Shareholders Own The Most Number of PCI Biotech Holding ASA (OB:PCIB) Shares?

Feb 15
What Type Of Shareholders Own The Most Number of PCI Biotech Holding ASA (OB:PCIB) Shares?

PCI Biotech Holding (OB:PCIB) Is In A Good Position To Deliver On Growth Plans

Dec 22
PCI Biotech Holding (OB:PCIB) Is In A Good Position To Deliver On Growth Plans

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PCI Biotech Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OB:PCIB - Analysts future estimates and past financials data (NOK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20246-16-15-15N/A
3/31/20244-18-15-15N/A
12/31/20233-20-15-15N/A
9/30/20233-23-23-23N/A
6/30/20233-29-30-30N/A
3/31/20234-38-43-43N/A
12/31/20225-55-59-59N/A
9/30/20225-73-66-66N/A
6/30/20225-84-70-70N/A
3/31/20226-88-69-69N/A
12/31/20216-88-69-68N/A
9/30/20217-90-68-67N/A
6/30/20217-90-77-76N/A
3/31/20217-100-79-76N/A
12/31/20207-72-81-77N/A
9/30/20208-71-87-81N/A
6/30/20208-64-85-79N/A
3/31/20209-61-93-88N/A
12/31/20199-89-87-82N/A
9/30/201910-68-75-72N/A
6/30/201910-62-62-60N/A
3/31/201910-43-44-44N/A
12/31/201810-35-40-40N/A
9/30/201810-46-34-34N/A
6/30/201810-48-35-35N/A
3/31/201810-48N/A-34N/A
12/31/201710-43N/A-31N/A
9/30/201710-34N/A-34N/A
6/30/201710-33N/A-36N/A
3/31/201710-35N/A-35N/A
12/31/201610-32N/A-36N/A
9/30/201611-34N/A-34N/A
6/30/201611-34N/A-33N/A
3/31/201610-31N/A-34N/A
12/31/201510-32N/A-33N/A
9/30/20159-34N/A-32N/A
6/30/20158-33N/A-32N/A
3/31/20158-34N/A-32N/A
12/31/20147-36N/A-32N/A
9/30/20148-35N/A-35N/A
6/30/20148-33N/A-33N/A
3/31/20147-30N/A-30N/A
12/31/20137-28N/A-29N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if PCIB's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if PCIB's earnings are forecast to grow faster than the Norwegian market

High Growth Earnings: Insufficient data to determine if PCIB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if PCIB's revenue is forecast to grow faster than the Norwegian market.

High Growth Revenue: Insufficient data to determine if PCIB's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if PCIB's Return on Equity is forecast to be high in 3 years time


Discover growth companies